Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2008 Sep 23;10538:14686-91. doi: 10.1073/pnas.0804372105.
Show Gene links
Show Anatomy links
Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
Young GT, Zwart R, Walker AS, Sher E, Millar NS.
???displayArticle.abstract???
Positive allosteric modulators of alpha7 nicotinic acetylcholine receptors (nAChRs) have attracted considerable interest as potential tools for the treatment of neurological and psychiatric disorders such as Alzheimer's disease and schizophrenia. However, despite the potential therapeutic usefulness of these compounds, little is known about their mechanism of action. Here, we have examined two allosteric potentiators of alpha7 nAChRs (PNU-120596 and LY-2087101). From studies with a series of subunit chimeras, we have identified the transmembrane regions of alpha7 as being critical in facilitating potentiation of agonist-evoked responses. Furthermore, we have identified five transmembrane amino acids that, when mutated, significantly reduce potentiation of alpha7 nAChRs. The amino acids we have identified are located within the alpha-helical transmembrane domains TM1 (S222 and A225), TM2 (M253), and TM4 (F455 and C459). Mutation of either A225 or M253 individually have particularly profound effects, reducing potentiation of EC(20) concentrations of acetylcholine to a tenth of the level seen with wild-type alpha7. Reference to homology models of the alpha7 nAChR, based on the 4A structure of the Torpedo nAChR, indicates that the side chains of all five amino acids point toward an intrasubunit cavity located between the four alpha-helical transmembrane domains. Computer docking simulations predict that the allosteric compounds such as PNU-120596 and LY-2087101 may bind within this intrasubunit cavity, much as neurosteroids and volatile anesthetics are thought to interact with GABA(A) and glycine receptors. Our findings suggest that this is a conserved modulatory allosteric site within neurotransmitter-gated ion channels.
Arneric,
Neuronal nicotinic receptors: a perspective on two decades of drug discovery research.
2007, Pubmed
Arneric,
Neuronal nicotinic receptors: a perspective on two decades of drug discovery research.
2007,
Pubmed Bertrand,
Allosteric modulation of nicotinic acetylcholine receptors.
2007,
Pubmed Broad,
Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
2006,
Pubmed
,
Xenbase Changeux,
Allosteric mechanisms of signal transduction.
2005,
Pubmed Changeux,
Nicotinic receptors, allosteric proteins and medicine.
2008,
Pubmed Cheng,
Channel opening motion of alpha7 nicotinic acetylcholine receptor as suggested by normal mode analysis.
2006,
Pubmed Couturier,
A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX.
1990,
Pubmed
,
Xenbase Eiselé,
Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities.
1993,
Pubmed
,
Xenbase Galzi,
The multiple phenotypes of allosteric receptor mutants.
1996,
Pubmed Garcia,
[3H]Benzophenone photolabeling identifies state-dependent changes in nicotinic acetylcholine receptor structure.
2007,
Pubmed
,
Xenbase Gee,
Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras.
2007,
Pubmed Gerzanich,
Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties.
1994,
Pubmed
,
Xenbase Grønlien,
Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
2007,
Pubmed
,
Xenbase Hansen,
Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
2007,
Pubmed Hetényi,
Blind docking of drug-sized compounds to proteins with up to a thousand residues.
2006,
Pubmed Hosie,
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites.
2006,
Pubmed Huey,
A semiempirical free energy force field with charge-based desolvation.
2007,
Pubmed Hurst,
A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
2005,
Pubmed
,
Xenbase Iorga,
Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the "blind docking" approach.
2006,
Pubmed Jensen,
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
2005,
Pubmed Le Novère,
The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences.
2002,
Pubmed Lester,
Cys-loop receptors: new twists and turns.
2004,
Pubmed Levin,
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
2007,
Pubmed Lobo,
Accessibility to residues in transmembrane segment four of the glycine receptor.
2006,
Pubmed Maricq,
Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel.
1991,
Pubmed
,
Xenbase Mihic,
Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors.
1997,
Pubmed
,
Xenbase Millar,
Assembly and subunit diversity of nicotinic acetylcholine receptors.
2003,
Pubmed Miyazawa,
Structure and gating mechanism of the acetylcholine receptor pore.
2003,
Pubmed MONOD,
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.
1965,
Pubmed Ng,
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.
2007,
Pubmed
,
Xenbase Ortells,
Evolutionary history of the ligand-gated ion-channel superfamily of receptors.
1995,
Pubmed Schrattenholz,
Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine.
1993,
Pubmed Taly,
Implications of the quaternary twist allosteric model for the physiology and pathology of nicotinic acetylcholine receptors.
2006,
Pubmed Taly,
Normal mode analysis suggests a quaternary twist model for the nicotinic receptor gating mechanism.
2005,
Pubmed Timmermann,
An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
2007,
Pubmed
,
Xenbase Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed Unwin,
Acetylcholine receptor channel imaged in the open state.
1995,
Pubmed Weiland,
Neuronal nicotinic acetylcholine receptors: from the gene to the disease.
2000,
Pubmed Ye,
Enhancement of glycine receptor function by ethanol is inversely correlated with molecular volume at position alpha267.
1998,
Pubmed
,
Xenbase Young,
Species selectivity of a nicotinic acetylcholine receptor agonist is conferred by two adjacent extracellular beta4 amino acids that are implicated in the coupling of binding to channel gating.
2007,
Pubmed Ziebell,
Identification of binding sites in the nicotinic acetylcholine receptor for [3H]azietomidate, a photoactivatable general anesthetic.
2004,
Pubmed
